News
Khondrion announces first patients dosed in 6-month paediatric Phase II study of sonlicromanol for mitochondrial diseases
Study will examine the pharmacokinetics, safety and efficacy of sonlicromanol, one of the most advanced disease-modifying drug candidates in development for mitochondrial disease
MedicalVR technology used for performing complex tumor removal
Next to lung, liver or heart surgeries, MedicalVR technology can be implemented in a multidisciplinary setting of plastic & reconstructive, oncologic and cardiotho
Toxys' ToxTracker performed very well in large PoC study by Proctor & Gamble
A proof of concept study of 18 chemicals comparing in vitro micronucleus, ToxTracker and genomics-based methods
LS@W alumnus Eline van Beest announced as Dutch winner of the first Henri Termeer Transatlantic Connections Award
The winners of the first Henri Termeer Transatlantic Connections Award have just been announced live in front of an online audience at the Innovation for Health event.
Five teams kick-off new Venture Challenge Spring edition
Five teams will be working from June to increase the chances of their technological invention in life sciences & health reaching the market.
Bi/ond announces new product: The MUSbit™
The whole Bi/ond team is excited to announce their newest product: The MUSbit™
NUTRIGUT consortium, coordinated by NutriLeads, wins Eurostars grant to develop next generation gut health ingredient
A consortium comprising Nutrileads (NL, coordinator), Ambiotis (FR), ProDigest (B) and Örebro University (SE) won a 3 years Eurostars grant for their innovative NUTRIGUT project.
Award Ceremony Proefdiervrij Venture Challenge
On the 23rd of April the award ceremony for the Proefdiervrij Venture Challenge will take place. After weeks of hard work, we will find out which team will go home with the grand prize of 25.000 euros.
Nice article in C2W (in Dutch) on Venture Challenge Winner AmbAgon
Drugging the undruggable. Esther Thole interviews Venture Challenge winner AmbAgon's founders Luc Brunsveld en Christian Ottmann for C2W.
Sirius Medical proudly announces first international implant
Sirius Medical, a start-up company developing Sirius Pintuition as an affordable, non-radioactive, point source localization technology that enables accurate surgical guidance in oncology is proud to announce the first international implants with the Sirius